Autonomix Medical (NASDAQ:AMIX) & Adagio Medical (NASDAQ:ADGM) Head to Head Survey

Autonomix Medical (NASDAQ:AMIX) and Adagio Medical (NASDAQ:ADGM) are both small-cap medical companies, but which is the superior investment? We will contrast the two companies based on the strength of their risk, analyst recommendations, valuation, earnings, institutional ownership, profitability and dividends.

Insider and Institutional Ownership

10.8% of Autonomix Medical shares are held by institutional investors. Comparatively, 48.1% of Adagio Medical shares are held by institutional investors. 32.4% of Autonomix Medical shares are held by company insiders. Comparatively, 53.5% of Adagio Medical shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term.

Analyst Ratings

This is a breakdown of recent ratings and target prices for Autonomix Medical and Adagio Medical, as reported by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Autonomix Medical	0	0	1	0	3.00
Adagio Medical	0	0	0	0	0.00

Autonomix Medical currently has a consensus target price of $28.00, suggesting a potential upside of 1,259.22%. Given Autonomix Medical’s stronger consensus rating and higher probable upside, research analysts clearly believe Autonomix Medical is more favorable than Adagio Medical.

Valuation and Earnings

This table compares Autonomix Medical and Adagio Medical”s revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Autonomix Medical	N/A	N/A	-$15.43 million	($12.93)	-0.16
Adagio Medical	$266,000.00	64.47	-$2.13 million	N/A	N/A

Adagio Medical has higher revenue and earnings than Autonomix Medical.

Profitability

This table compares Autonomix Medical and Adagio Medical’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Autonomix Medical	N/A	-212.48%	-161.13%
Adagio Medical	N/A	160.59%	40.99%

Volatility & Risk

Autonomix Medical has a beta of -5.4, meaning that its stock price is 640% less volatile than the S&P 500. Comparatively, Adagio Medical has a beta of 0.21, meaning that its stock price is 79% less volatile than the S&P 500.

Summary

Adagio Medical beats Autonomix Medical on 7 of the 10 factors compared between the two stocks.

About Autonomix Medical

Autonomix Medical, Inc., a development stage medical device development company, focuses on advancing technologies for sensing and treating disorders relating to the peripheral nervous system. Its technology platform includes a catheter-based microchip-enabled sensing array to detect and differentiate peripheral neural signals. The company was incorporated in 2014 and is based in The Woodlands, Texas.

About Adagio Medical

Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company’s product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. The company is based in Laguna Hills, California.